Cargando…

Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report

INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. CASE PRESENTATION: We report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerbib, Yoann, Gibert, Louis, Bennis, Youssef, Masmoudi, Kamel, Maizel, Julien, Brault, Clément
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935013/
https://www.ncbi.nlm.nih.gov/pubmed/35321464
http://dx.doi.org/10.3389/fmed.2022.837324
_version_ 1784671955606044672
author Zerbib, Yoann
Gibert, Louis
Bennis, Youssef
Masmoudi, Kamel
Maizel, Julien
Brault, Clément
author_facet Zerbib, Yoann
Gibert, Louis
Bennis, Youssef
Masmoudi, Kamel
Maizel, Julien
Brault, Clément
author_sort Zerbib, Yoann
collection PubMed
description INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. CASE PRESENTATION: We report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted to the emergency department with mental confusion, blurred vision, headaches, and vomiting, following self-medication with an oral decongestant containing pseudoephedrine. We observed hypointense lesions with T1-weighted MRI and hyperintense areas with T2-weighted and fluid-attenuated inversion recovery MRI sequences. The lack of diffusion restriction was consistent with a diagnosis of PRES. A concomitant Enterobacter cloacae hemodialysis catheter-bloodstream infection was also diagnosed. We hypothesize that both sepsis and inappropriate self-medication with oral pseudoephedrine contributed to hypertension, endothelial dysfunction, and vasogenic edema. The patient received intensive care and made a full recovery. DISCUSSION: PRES is a life-threatening condition that requires intensive care. Identification of the etiology is the keystone of medical care. Inappropriate self-medication with an oral decongestant might trigger PRES - highlighting the importance of patient education.
format Online
Article
Text
id pubmed-8935013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89350132022-03-22 Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report Zerbib, Yoann Gibert, Louis Bennis, Youssef Masmoudi, Kamel Maizel, Julien Brault, Clément Front Med (Lausanne) Medicine INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a rare neurological disorder caused by the dysregulation of cerebral perfusion. CASE PRESENTATION: We report on a 18-year-old female patient with a history of end-stage renal disease and thrice weekly hemodialysis. She was admitted to the emergency department with mental confusion, blurred vision, headaches, and vomiting, following self-medication with an oral decongestant containing pseudoephedrine. We observed hypointense lesions with T1-weighted MRI and hyperintense areas with T2-weighted and fluid-attenuated inversion recovery MRI sequences. The lack of diffusion restriction was consistent with a diagnosis of PRES. A concomitant Enterobacter cloacae hemodialysis catheter-bloodstream infection was also diagnosed. We hypothesize that both sepsis and inappropriate self-medication with oral pseudoephedrine contributed to hypertension, endothelial dysfunction, and vasogenic edema. The patient received intensive care and made a full recovery. DISCUSSION: PRES is a life-threatening condition that requires intensive care. Identification of the etiology is the keystone of medical care. Inappropriate self-medication with an oral decongestant might trigger PRES - highlighting the importance of patient education. Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8935013/ /pubmed/35321464 http://dx.doi.org/10.3389/fmed.2022.837324 Text en Copyright © 2022 Zerbib, Gibert, Bennis, Masmoudi, Maizel and Brault. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Zerbib, Yoann
Gibert, Louis
Bennis, Youssef
Masmoudi, Kamel
Maizel, Julien
Brault, Clément
Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
title Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
title_full Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
title_fullStr Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
title_full_unstemmed Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
title_short Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report
title_sort posterior reversible encephalopathy syndrome after self-medication with an oral decongestant: a case report
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935013/
https://www.ncbi.nlm.nih.gov/pubmed/35321464
http://dx.doi.org/10.3389/fmed.2022.837324
work_keys_str_mv AT zerbibyoann posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport
AT gibertlouis posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport
AT bennisyoussef posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport
AT masmoudikamel posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport
AT maizeljulien posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport
AT braultclement posteriorreversibleencephalopathysyndromeafterselfmedicationwithanoraldecongestantacasereport